Black Friday Doorbuster Recombinant Mers-cov Spike/s1 Protein (s1 Subunit, Aa 1-725, His Tag), Hplc-verified Holiday Cheer Edition [b6huvsgt]

Recombinant MERS-CoV Spike/S1 Protein: Cutting-Edge Research Tool

The Recombinant MERS-CoV Spike/S1 Protein is a high-quality research tool designed for advanced virology studies. This protein is produced through a recombinant process using HEK293 cells, ensuring a consistent and reliable supply for your research needs. The S1 subunit, spanning amino acids 1-725, is tagged with a His Tag for easy purification and detection. With an observed molecular weight of 94 kDa and a calculated molecular weight of 79.9 kDa, this protein is ideal for various applications, including antibody production, ELISA, and immunodetection.

• High purity > 95% as verified by reducing SDS-PAGE
• Expression Host: HEK293 Cells

Product Properties and Specifications

This recombinant protein is HPLC-verified for purity and quality assurance. It is endotoxin-free, with less than 1.0 EU per μg, ensuring minimal interference in your experiments. The protein is lyophilized from sterile PBS, pH 7.4, with stabilizers added to maintain its stability during storage. Storage conditions are optimized for long-term stability, with lyophilized powder stable for up to 12 months at -20 to -80℃ and reconstituted protein solutions stable for 2-7 days at 4-8℃.

• Endotoxin < 1.0 EU per μg
• Storage conditions: -20 to -80℃ for lyophilized powder, 4-8℃ for reconstituted protein

Applications and Benefits

The Recombinant MERS-CoV Spike/S1 Protein is a versatile tool for researchers studying coronaviruses and their interaction with host cells. Its key features make it ideal for various applications, such as developing vaccines, understanding viral pathogenesis, and identifying therapeutic targets. This protein is suitable for use in research institutions, biotech companies, and pharmaceutical organizations, providing a valuable resource for advancing the fight against MERS-CoV and other coronaviruses.

• Applications: Vaccine development, antibody production, ELISA, immunodetection
• Target Audience: Researchers in virology, immunology, and infectious diseases